Rivastigmine and International normalised ratio increased - a phase IV clinical study of FDA data

Summary:

International normalised ratio increased is reported as a side effect among people who take Rivastigmine (rivastigmine tartrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Warfarin Sodium, and have High blood cholesterol.

The phase IV clinical study analyzes which people have International normalised ratio increased when taking Rivastigmine. It is created by eHealthMe based on reports of 7,475 people who have side effects when taking Rivastigmine from the FDA, and is updated regularly.

What is Rivastigmine?

Rivastigmine has active ingredients of rivastigmine tartrate. It is often used in dementia. eHealthMe is studying from 7,517 Rivastigmine users. Check the latest studies of Rivastigmine.

What is International normalised ratio increased?

International normalised ratio increased is found to be associated with 1,333 drugs and 1,727 conditions by eHealthMe. Check the latest studies of International normalised ratio increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

7,475 people reported to have side effects when taking Rivastigmine.
Among them, 17 people (0.23%) have International normalised ratio increased.

Could Rivastigmine cause International normalised ratio increased?

Among these 17 people:

How long have people been on Rivastigmine when they have International normalised ratio increased? *

What is the gender of people who have International normalised ratio increased when taking Rivastigmine? *

female: 70.59 %
male: 29.41 %

What is the age of people who have International normalised ratio increased when taking Rivastigmine? *

What are other drugs people take besides Rivastigmine? *

Atenolol: 7 people, 41.18%
Warfarin Sodium: 7 people, 41.18%
Fludrocortisone Acetate: 5 people, 29.41%
Hydrocortisone: 4 people, 23.53%
Enalapril Maleate: 3 people, 17.65%
Gabapentin: 2 people, 11.76%
Albuterol Sulfate: 2 people, 11.76%
Amlodipine: 2 people, 11.76%
Antivert: 2 people, 11.76%
Carvedilol: 2 people, 11.76%

What are other side effects people have besides International normalised ratio increased? *

Abdominal Wall Haemorrhage (bleeding from injured abdominal organs): 5 people, 29.41%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 17.65%
Headache (pain in head): 3 people, 17.65%
Memory Loss: 3 people, 17.65%
Fall: 3 people, 17.65%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 11.76%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 2 people, 11.76%
Eye Pain: 2 people, 11.76%
Dyspnea (difficult or laboured breathing): 2 people, 11.76%
Drowsiness: 2 people, 11.76%

What are the existing conditions these people have? *

Addison's Disease (addison's disease, a hormonal disorder disease): 4 people, 23.53%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 23.53%
High Blood Pressure: 4 people, 23.53%
High Blood Cholesterol: 4 people, 23.53%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 11.76%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 11.76%
Dry Eyes (lack of adequate tears): 1 person, 5.88%
Allergic Rhinitis: 1 person, 5.88%
Arrhythmias (irregular heartbeat): 1 person, 5.88%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Rivastigmine and have International normalised ratio increased?

- Check whether International normalised ratio increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivastigmine:

Rivastigmine (7,517 reports)

International normalised ratio increased treatments and more:

International normalised ratio increased (40,071 reports)

How severe was International normalised ratio increased and when was it recovered:

International normalised ratio increased in Rivastigmine

Expand to all the drugs that have ingredients of rivastigmine tartrate:

International normalised ratio increased and drugs with ingredients of rivastigmine tartrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rivastigmine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with International normalised ratio increased:

International normalised ratio increased (1,333 drugs)

Browse all the conditions that are associated with International normalised ratio increased:

International normalised ratio increased (1,727 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Rivastigmine) and Rivastigmine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.